David C. Montefiori

Active 1981–2025

Also published as
David C Montefiori
418
Papers
72,600
Citations
144
h-index
407
i10-index

Citations

Citations per year for David C. Montefiori1985: 2 citations1988: 4 citations1989: 2 citations1990: 8 citations1991: 11 citations1992: 10 citations1993: 22 citations1994: 12 citations1995: 26 citations1996: 43 citations1997: 96 citations1998: 121 citations1999: 132 citations2000: 211 citations2001: 248 citations2002: 366 citations2003: 335 citations2004: 435 citations2005: 408 citations2006: 457 citations2007: 317 citations2008: 350 citations2009: 409 citations2010: 441 citations2011: 496 citations2012: 490 citations2013: 595 citations2014: 511 citations2015: 527 citations2016: 505 citations2017: 610 citations2018: 494 citations2019: 1,731 citations2020: 2,094 citations2021: 3,235 citations2022: 2,747 citations2023: 1,513 citations2024: 2,194 citations2025: 906 citations2026: 16 citations1986–1987: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 6,554 citing papers, 36.2% of this breakdownUnited Kingdom: 1,262 citing papers, 7% of this breakdownChina: 1,194 citing papers, 6.6% of this breakdownGermany: 716 citing papers, 4% of this breakdownCanada: 628 citing papers, 3.5% of this breakdownFrance: 570 citing papers, 3.1% of this breakdownNetherlands: 524 citing papers, 2.9% of this breakdownAustralia: 442 citing papers, 2.4% of this breakdownSouth Africa: 426 citing papers, 2.4% of this breakdownItaly: 425 citing papers, 2.3% of this breakdownIndia: 412 citing papers, 2.3% of this breakdownSwitzerland: 371 citing papers, 2% of this breakdown
0%36.2%Other 25.3%

Fields

  • Medicine48.9%
  • Immunology and Microbiology35.8%
  • Biochemistry, Genetics and Molecular Biology10.8%
  • Agricultural and Biological Sciences0.8%
  • Mathematics0.5%
  • Environmental Science0.5%
  • Other2.7%

Topics

  • SARS-CoV-2 and COVID-19 Research13%
  • HIV Research and Treatment10.8%
  • Immune Cell Function and Interaction5.3%
  • COVID-19 Clinical Research Studies5.3%
  • Immunotherapy and Immune Responses4.1%
  • vaccines and immunoinformatics approaches3.9%
  • Other57.6%

Coauthors

All papers

Open in search
  1. Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Colleen F. Kelley, Michele P. Andrasik, James G. Kublin, Lawrence Corey, Kathleen M. Neuzil, Lindsay N. Carpp, Rolando Pajón, Dean Follmann, Rubén O. Donis, Richard A. Koup, Immune Assays Team§, Coronavirus Vaccine Prevention Network (CoVPN)/Coronavirus Efficacy (COVE) Team§, United States Government (USG)/CoVPN Biostatistics Team§ - Science 2022 cited by 1,211

  2. Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Matthew D. Wyles, Charlene McDanal, Lautaro G. Perez, Haili Tang, Alex Moon-Walker, Sean P. J. Whelan, Celia C. LaBranche, Erica O. Saphire, David C. Montefiori - Cell 2020 cited by 4,491

  3. Two Randomized Trials of Neutralizing Antibodies to Prevent HIV-1 Acquisition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Simbarashe Takuva, Margarita M. Gomez Lorenzo, David Burns, Nicole Espy, April K. Randhawa, Nidhi Kochar, Estelle Piwowar‐Manning, Deborah Donnell, Nirupama Sista, P. Andrew, James G. Kublin, Glenda Gray, Julie E. Ledgerwood, John R. Mascola, Myron S. Cohen - New England Journal of Medicine 2021 cited by 539

  4. Vaccination induces HIV broadly neutralizing antibody precursors in humans

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David M. Brown, David R. Ambrozak, Troy Sincomb, Xiaozhen Hu, Ryan Tingle, Erik Georgeson, Saman Eskandarzadeh, Nushin Alavi, Danny Lu, Tina-Marie Mullen, Michael Kubitz, Bettina Gröschel, Janine Maenza, Orpheus Kolokythas, Nadia J. Khati, Jeffrey M. Bethony, Shane Crotty, Mario Roederer, Gunilla B. Karlsson Hedestam, Georgia D. Tomaras, David C. Montefiori, David Diemert, Richard A. Koup, Dagna Laufer, M. Juliana McElrath, Adrian B. McDermott, William R. Schief - Science 2022 cited by 272

  5. Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas D. Madden, Michael J. Hope, Mark G. Lewis, Kelly K. Lee, Shiu‐Lok Hu, Scott E. Hensley, Michael P. Cancro, Barton F. Haynes, Drew Weissman - The Journal of Experimental Medicine 2018 cited by 527

  6. Long-primed germinal centres with enduring affinity maturation and clonal migration

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David C. Montefiori, Ronald S. Veazey, Andrew B. Ward, Lars Hangartner, Dennis R. Burton, Darrell J. Irvine, William R. Schief, Shane Crotty - Nature 2022 cited by 192

  7. Homologous and Heterologous Covid-19 Booster Vaccinations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Adrian B. McDermott, Sarah O’Connell, David C. Montefiori, Amanda Eaton, Kathleen M. Neuzil, David S. Stephens, Paul C. Roberts, John H. Beigel - New England Journal of Medicine 2022 cited by 618

  8. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Skye Spencer, Lara Doyle‐Meyers, Rudolph P. Bohm, Nicholas J. Maness, Chad J. Roy, Jessica A. Plante, Kenneth S. Plante, Alex Zhu, Matthew J. Gorman, Sally Shin, Xiaoying Shen, Jane Fontenot, Shakti Gupta, Derek T. O’Hagan, Robbert van der Most, Rino Rappuoli, Robert L. Coffman, David Novack, Jason S. McLellan, Shankar Subramaniam, David C. Montefiori, Scott D. Boyd, JoAnne L. Flynn, Galit Alter, François Villinger, Harry Kleanthous, Jay Rappaport, Mehul S. Suthar, Neil P. King, David Veesler, Bali Pulendran - Nature 2021 cited by 353

  9. Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Jack Greenhouse, Swagata Kar, Laurent Pessaint, Maciel Porto, Katelyn Steingrebe, Daniel Valentin, Serge Zouantcha, Kevin W. Bock, Mahnaz Minai, Bianca M. Nagata, Renee van de Wetering, Seyhan Boyoglu-Barnum, Kwanyee Leung, Wei Shi, Eun Sung Yang, Yi Zhang, John-Paul Todd, Lingshu Wang, Gabriela Alvarado, Hanné Andersen, Kathryn E. Foulds, Darin K. Edwards, John R. Mascola, Ian N. Moore, Mark G. Lewis, Andrea Carfı́, David C. Montefiori, Mehul S. Suthar, Adrian B. McDermott, Mario Roederer, Nancy J. Sullivan, Daniel C. Douek, Barney S. Graham, Robert A. Seder - Science 2021 cited by 329

  10. Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1

    Authors: , , , , , , , , , , , - Journal of Immunological Methods 2013 cited by 585

  11. mRNA-encoded HIV-1 Env trimer ferritin nanoparticles induce monoclonal antibodies that neutralize heterologous HIV-1 isolates in mice

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barton F. Haynes - Cell Reports 2022 cited by 80

  12. Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Phillip W. Berman, Nicole Frahm, Stephen C. De Rosa, Michael D. Alpert, Nicole L. Yates, Xiaoying Shen, Richard A. Koup, Punnee Pitisuttithum, Jaranit Kaewkungwal, Sorachai Nitayaphan, Supachai Rerks‐Ngarm, Nelson L. Michael, Jérôme H. Kim - New England Journal of Medicine 2012 cited by 1,834

  13. Measuring HIV Neutralization in a Luciferase Reporter Gene Assay

    Authors: - Methods in molecular biology 2009 cited by 600

  14. In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Laura L. Sutherland, David C. Montefiori, Robert J. Edwards, Kevin O. Saunders, Charlene McDanal, Giovanna E. Hernandez, Katayoun Mansouri, Robert E. Parks, Xiaozhi Lu, Blake M. Hauser, C. Todd DeMarco, Fangping Cai, Barney S. Graham, Kevin Wiehe, John R. Mascola, Gregory D. Sempowski, Hanné Andersen, Elizabeth Petzold, David R. Martinez, Peter D. Kwong, Victoria Gee-Lai, Megan Kopp, S. Gobeil, Victoria Stalls, Aja Sanzone, Wes Rountree, Barton F. Haynes, Mark G. Lewis, Priyamvada Acharya, Thomas H. Oguin, Chuancang Jiang, I‐Ting Teng, Andrew Foulger, Christopher W. Woods - Cell 2021 cited by 334

  15. Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Cathy Masiello, Baishali Maskeri, Jenny McDowell, Casandra Montemayor, James C. Mullikin, Morgan Park, Nancy Riebow, Karen Schandler, Brian Schmidt, Christina Sison, Mal Stantripop, James Thomas, Pam Thomas, Meg Vemulapalli, Alice Young, James C. Mullikin, S. Gnanakaran, Peter Hraber, Kevin Wiehe, Garnett Kelsoe, Guang Yang, Shi-Mao Xia, David C. Montefiori, Robert E. Parks, Krissey E. Lloyd, Richard M. Scearce, Kelly A. Soderberg, Myron S. Cohen, Gift Kamanga, Mark K. Louder, Lillian Tran, Yue Chen, Fangping Cai, Sheri Chen, Stephanie Moquin, Xiulian Du, M. Gordon Joyce, Sanjay Srivatsan, Baoshan Zhang, Anqi Zheng, George M. Shaw, Beatrice H. Hahn, Thomas B. Kepler, Bette Korber, Peter D. Kwong, John R. Mascola, B F Haynes - Nature 2013 cited by 1,061

  16. Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Frances Priddy, Erica Lazarus, Fatima Laher, Sorachai Nitayapan, Punnee Pitisuttithum, Stephan Bart, Thomas Campbell, Robert Feldman, Gregg Lucksinger, Caroline Borremans, Katleen Callewaert, Raphaele Roten, Jerald Sadoff, Lorenz Scheppler, Mo Weijtens, Karin Feddes-de Boer, Daniëlle van Manen, Jessica Vreugdenhil, Roland Zahn, Ludo Lavreys, Steven Nijs, Jeroen Tolboom, Jenny Hendriks, Zelda Euler, Maria Grazia Pau, Hanneke Schuitemaker - The Lancet 2018 cited by 342

  17. Neutralizing antibody vaccine for pandemic and pre-emergent coronaviruses

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Thomas H. Oguin, Gregory D. Sempowski, Matthew Gagné, Daniel C. Douek, Mark A. Tomai, Christopher B. Fox, Robert A. Seder, Kevin Wiehe, Drew Weissman, Norbert Pardi, Hana Golding, Surender Khurana, Priyamvada Acharya, Hanné Andersen, Mark G. Lewis, Ian N. Moore, David C. Montefiori, Ralph S. Baric, Barton F. Haynes - Nature 2021 cited by 276

  18. Structural diversity of the SARS-CoV-2 Omicron spike

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Molecular Cell 2022 cited by 219

  19. Safety and immunogenicity of SARS-CoV-2 variant mRNA vaccine boosters in healthy adults: an interim analysis

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2021 cited by 449

  20. Enhancing and shaping the immunogenicity of native-like HIV-1 envelope trimers with a two-component protein nanoparticle

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rogier W. Sanders - Nature Communications 2019 cited by 213

  21. Defining the risk of SARS-CoV-2 variants on immune protection

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ali H. Ellebedy, Thomas Fabrizio, Guido Ferrari, Will Fischer, William C. Florence, Ron A. M. Fouchier, John Franks, Adolfo Garcı́a-Sastre, Adam Godzik, Ana S. Gonzalez‐Reiche, Aubree Gordon, Bart L. Haagmans, Peter Halfmann, David D. Ho, Michael R. Holbrook, Yaoxing Huang, Sarah L. James, Lukasz Jaroszewski, Trushar Jeevan, Robert M. Johnson, Terry C. Jones, Astha Joshi, Yoshihiro Kawaoka, Lisa Kercher, Marion Koopmans, Bette Korber, Eilay Koren, Richard A. Koup, Eric B. LeGresley, Jacob E. Lemieux, Mariel J. Liebeskind, Zhuoming Liu, Brandi Livingston, James Logue, Yang Luo, Adrian B. McDermott, Margaret Juliana McElrath, Victoria Meliopoulos, Vineet D. Menachery, David C. Montefiori, Barbara Mühlemann, Vincent J. Munster, Jenny Munt, Manoj S. Nair, Antonia Netzl, Anna Maria Niewiadomska, Sijy O’Dell, Andrew Pekosz, Stanley Perlman, Marjorie Cornejo Pontelli, Barry Rockx, Morgane Rolland, Paul W. Rothlauf, Sinai Sacharen, Richard H. Scheuermann, Stephen D. Schmidt, Michael Schotsaert, Stacey Schultz‐Cherry, Robert A. Seder, Mayya Sedova, Alessandro Sette, Reed S. Shabman, Xiaoying Shen, Pei‐Yong Shi, Maulik Shukla, Viviana Simon, Spencer Stumpf, Nancy J. Sullivan, Larissa B. Thackray, James Theiler and 30 more - Nature 2022 cited by 185

  22. Evaluation of mRNA-1273 Covid-19 Vaccine in Children 6 to 11 Years of Age

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2022 cited by 175

  23. Neutralization titer biomarker for antibody-mediated prevention of HIV-1 acquisition

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kelvin Chiong, Georgia D. Tomaras, P. Andrew, Bryan T. Mayer, Daniel B. Reeves, Magdalena E. Sobieszczyk, Nigel Garrett, Jorge Sánchez, Cynthia L. Gay, Joseph Makhema, Carolyn Williamson, James I. Mullins, John Hural, Myron S. Cohen, Lawrence Corey, David C. Montefiori, Lynn Morris - Nature Medicine 2022 cited by 126

  24. Safety and Immunogenicity of XBB.1.5-Containing mRNA Vaccines

    Authors: , , , , , , , , , , , , , , , , , - medRxiv 2023 cited by 79